24Sep
Northern District Of Illinois Dismisses Putative Class Action Against Pharmaceutical Company For Failure To Adequately Allege Falsity Or Scienter
On September 18, 2019, Judge Charles P. Kocoras of the United States District Court for the Northern District of Illinois dismissed a putative class action against a pharmaceutical company asserting claims under Section 10(b) of the Securities...
By:
Shearman & Sterling LLP
Related
Illinois recently enacted sweeping legislation in an effort to combat sexual harassment in the workp...
Read More >
In a recent settled administrative proceeding, the Securities and Exchange Commission (SEC or the Co...
Read More >
Having recently helped a client determine if it employed on average more than 50 employees per month...
Read More >
In anticipation of its November Board meeting this past week, the Medical Board released its Medical...
Read More >
The Federal Trade Commission and the U.S. Department of Justice this week announced the final versio...
Read More >
McDermott was delighted to partner with the BVCA (British Venture Capital Association) on its recent...
Read More >